Beyond Members of the

Animals Animals, Newborn Antiviral Agents / therapeutic use Arthralgia / drug therapy Chikungunya Fever / drug therapy Chikungunya virus / drug effects Humans Male Mice Sofosbuvir / therapeutic use Virus Replication / drug effects
antiviral arthralgia chikungunya chikungunya virus drug sofosbuvir

Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
02 2019
Historique:
received: 04 07 2018
accepted: 31 10 2018
pubmed: 21 11 2018
medline: 28 1 2020
entrez: 21 11 2018
Statut: epublish

Résumé

Chikungunya virus (CHIKV) causes a febrile disease associated with chronic arthralgia, which may progress to neurological impairment. Chikungunya fever (CF) is an ongoing public health problem in tropical and subtropical regions of the world, where control of the CHIKV vector,

Identifiants

DOI: 10.1128/AAC.01389-18 PMID: 30455237 PMC: PMC6355571
pubmed: 30455237
pii: AAC.01389-18
doi: 10.1128/AAC.01389-18
pmc: PMC6355571
pii:
doi:

Substances chimiques

Antiviral Agents 0
Sofosbuvir WJ6CA3ZU8B

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

Sci Rep. 2017 Jan 18;7:40920
pubmed: 28098253
Nat Methods. 2015 Jan;12(1):7-8
pubmed: 25549265
J Biol Chem. 2000 Aug 18;275(33):25523-32
pubmed: 10827187
Methods Enzymol. 1997;277:396-404
pubmed: 9379925
Sci Rep. 2016 Oct 07;6:34793
pubmed: 27713505
Bioorg Med Chem. 2017 Aug 15;25(16):4219-4244
pubmed: 28689975
Antiviral Res. 2017 Jul;143:38-47
pubmed: 28390873
J Infect Dis. 2016 Dec 15;214(suppl 5):S446-S448
pubmed: 27920171
Emerg Infect Dis. 2017 Oct;23(10):1742-1744
pubmed: 28930031
Antiviral Res. 2016 Feb;126:117-24
pubmed: 26752081
J Neurosci. 2017 Feb 22;37(8):2161-2175
pubmed: 28123079
Cell Rep. 2016 Sep 6;16(10):2576-2592
pubmed: 27568284
Biochemistry. 1992 Oct 13;31(40):9609-21
pubmed: 1327122
Arq Neuropsiquiatr. 2016 Nov;74(11):937-943
pubmed: 27901259
J Pharmacol Pharmacother. 2014 Oct;5(4):278-84
pubmed: 25422576
Science. 2016 May 13;352(6287):816-8
pubmed: 27064148
Antiviral Res. 2011 Jan;89(1):1-8
pubmed: 21070810
Stem Cells Transl Med. 2013 Nov;2(11):862-70
pubmed: 24113065
Curr Infect Dis Rep. 2017 Feb;19(2):6
pubmed: 28233188
J Virol. 2016 Oct 14;90(21):9743-9757
pubmed: 27535052
Microbiol Rev. 1994 Sep;58(3):491-562
pubmed: 7968923
Antiviral Res. 2015 Sep;121:59-68
pubmed: 26119058
PLoS Negl Trop Dis. 2014 Aug 07;8(8):e3077
pubmed: 25101628
J Virol. 2010 Aug;84(16):8021-32
pubmed: 20519386
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
Sci Rep. 2017 Aug 25;7(1):9409
pubmed: 28842610
J Neurovirol. 2016 Apr;22(2):140-8
pubmed: 26419894
J Biol Chem. 2014 Feb 28;289(9):5635-53
pubmed: 24407286
Org Lett. 2006 Aug 3;8(16):3613-5
pubmed: 16869673
Biomed Pharmacother. 2017 Mar;87:302-310
pubmed: 28063412
Emerg Infect Dis. 2007 May;13(5):764-7
pubmed: 17553261
Antiviral Res. 2017 Jan;137:134-140
pubmed: 27902933
Viruses. 2017 Dec 01;9(12):
pubmed: 29194359
Lancet Infect Dis. 2007 May;7(5):319-27
pubmed: 17448935
PLoS One. 2015 May 13;10(5):e0126360
pubmed: 25970853
PLoS Curr. 2017 Feb 14;9:
pubmed: 28286701
J Antimicrob Chemother. 2012 Aug;67(8):1884-94
pubmed: 22535622
Antiviral Res. 2004 Feb;61(2):111-7
pubmed: 14670584
BMC Med. 2015 Apr 30;13:102
pubmed: 25976325
Nucleic Acids Res. 2003 Jul 1;31(13):3784-8
pubmed: 12824418
J Med Chem. 2013 Feb 14;56(3):1074-83
pubmed: 23298236
Sci Rep. 2017 Jul 24;7(1):6345
pubmed: 28740124
PLoS Negl Trop Dis. 2019 Jan 30;13(1):e0007072
pubmed: 30699122
Cancer Res. 1988 Sep 1;48(17):4827-33
pubmed: 3409223
Antimicrob Agents Chemother. 2013 Jan;57(1):155-67
pubmed: 23275491
J Virol. 2013 Dec;87(24):13878-88
pubmed: 24131709
J Med Chem. 2010 Oct 14;53(19):7202-18
pubmed: 20845908
Trans R Soc Trop Med Hyg. 1957 May;51(3):238-40
pubmed: 13443013
Osteoarthritis Cartilage. 2012 Apr;20(4):256-60
pubmed: 22424462
J Vector Borne Dis. 2009 Mar;46(1):26-35
pubmed: 19326705
Lancet Respir Med. 2014 May;2(5):395-404
pubmed: 24815805
PLoS Negl Trop Dis. 2013 Oct 31;7(10):e2471
pubmed: 24205414
PLoS Negl Trop Dis. 2014 Jun 26;8(6):e2921
pubmed: 24967777
J Antimicrob Chemother. 2014 Oct;69(10):2770-84
pubmed: 24951535
Virus Res. 2018 Jan 15;244:64-70
pubmed: 29113824
J Med Chem. 2006 Jun 1;49(11):3315-21
pubmed: 16722650
J Infect Dis. 2016 Oct 15;214(8):1192-7
pubmed: 27496974

Auteurs

André C Ferreira (AC)

Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.
Instituto Nacional de Infectologia (INI), Fiocruz, Rio de Janeiro, Brazil.
National Institute for Science and Technology on Innovation on Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, Brazil.

Patrícia A Reis (PA)

Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.

Caroline S de Freitas (CS)

Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.
National Institute for Science and Technology on Innovation on Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, Brazil.

Carolina Q Sacramento (CQ)

Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.
National Institute for Science and Technology on Innovation on Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, Brazil.

Lucas Villas Bôas Hoelz (L)

Instituto de Tecnologia de Fármacos (Farmanguinhos), Fiocruz, Rio de Janeiro, Brazil.

Mônica M Bastos (MM)

Instituto de Tecnologia de Fármacos (Farmanguinhos), Fiocruz, Rio de Janeiro, Brazil.

Mayara Mattos (M)

Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.
National Institute for Science and Technology on Innovation on Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, Brazil.

Natasha Rocha (N)

Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.
National Institute for Science and Technology on Innovation on Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, Brazil.

Isaclaudia Gomes de Azevedo Quintanilha (I)

Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.

Carolina da Silva Gouveia Pedrosa (C)

D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil.

Leticia Rocha Quintino Souza (L)

D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil.

Erick Correia Loiola (E)

D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil.

Pablo Trindade (P)

D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil.

Yasmine Rangel Vieira (Y)

Instituto Nacional de Infectologia (INI), Fiocruz, Rio de Janeiro, Brazil.
National Institute for Science and Technology on Innovation on Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, Brazil.

Giselle Barbosa-Lima (G)

Instituto Nacional de Infectologia (INI), Fiocruz, Rio de Janeiro, Brazil.

Hugo C de Castro Faria Neto (HC)

Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.

Nubia Boechat (N)

Instituto de Tecnologia de Fármacos (Farmanguinhos), Fiocruz, Rio de Janeiro, Brazil.

Stevens K Rehen (SK)

D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil.
Centro de Ciências da Saúde, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

Karin Brüning (K)

BMK Consortium, Rio de Janeiro, Brazil.

Fernando A Bozza (FA)

Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.
Instituto Nacional de Infectologia (INI), Fiocruz, Rio de Janeiro, Brazil.

Patrícia T Bozza (PT)

Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.

Thiago Moreno L Souza (TML)

Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil tmoreno@cdts.fiocruz.br.
Instituto Nacional de Infectologia (INI), Fiocruz, Rio de Janeiro, Brazil.
National Institute for Science and Technology on Innovation on Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, Brazil.
ORCID: 0000-0003-2212-3899

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Beyond Members of the
questionsmedicales.fr › Eucaryotes › Animaux › Groupes animaux › Animaux nouveau-nés › Beyond Members of the
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antiviraux › Beyond Members of the
questionsmedicales.fr › Phénomènes physiologiques de l'appareil locomoteur et du système nerveux › Phénomènes physiologiques du système nerveux › Sensation › Douleur › Arthralgie › Beyond Members of the
questionsmedicales.fr › Infection › Maladies virales › Infections à virus à ARN › Infections à Togaviridae › Infections à alphavirus › Fièvre chikungunya › Beyond Members of the
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Togaviridae › Alphavirus › Virus du chikungunya › Beyond Members of the
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Beyond Members of the
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Beyond Members of the
questionsmedicales.fr › Acides nucléiques, nucléotides et nucléosides › Nucléotides › Ribonucléotides › Nucléotides uridyliques › Uridine monophosphate › Sofosbuvir › Beyond Members of the
questionsmedicales.fr › Phénomènes microbiologiques › Phénomènes physiologiques viraux › Réplication virale › Beyond Members of the